Anti-KIAA2026 antibody (bs-17038R)

Anti-KIAA2026 antibody

DATASHEET

Host:Rabbit

Target Protein:KIAA2026

IR:Immunogen Range:1-100/2103

Clonality:Polyclonal

Isotype:IgG

Entrez Gene:158358

Swiss Prot:Q5HYC2

Source:KLH conjugated synthetic peptide derived from human KIAA2026:1-100/2103 

Purification:affinity purified by Protein A

Storage:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.

Background:KIAA2026 is a 2,103 amino acid protein that exists as two alternatively spliced isoforms and is encoded by a gene that maps to human chromosome 9p24.1. Consisting of about 145 million bases, chromosome 9 makes up approximately 4% of the human genome and encodes nearly 900 genes. Thought to play a role in gender determination, deletion of the distal portion of 9p can lead to development of male to female sex reversal, the phenotype of a female with a male X,Y genotype. Hereditary hemorrhagic telangiectasia, which is characterized by harmful vascular defects, is associated with the chromosome 9 gene encoding endoglin protein, ENG. Familial dysautonomia is also associated with chromosome 9 though through the gene IKBKAP. Notably, chromosome 9 encompasses the largest interferon family gene cluster. Chromosome 9 is partnered with chromosome 22 in the translocation leading to the aberrant production of BCR-ABL fusion protein often found in leukemias.

Size:100ul

Concentration:1mg/ml

Applications:

Cross Reactive Species:Human
.

For research use only. Not intended for diagnostic or therapeutic use.